Problems of mental disorder in the context of the COVID-19 pandemic
DOI: 10.32364/2587-6821-2023-7-10-7
P.I. Litvinenko1, O.V. Tsygankova2,3, L.D. Khidirova2,4, A.A. Starichkova2,5
1Clinical Hospital "RZD-Medicine", Novosibirsk, Russian Federation
2Novosibirsk State Medical University, Novosibirsk, Russian Federation
3Research Institute for Therapy and Preventive Medicine — Branch of the Federal Research Center Institute of Cytology and Genetics of the Siberian Branch of the RAS, Novosibirsk, Russian Federation
4Novosibirsk Regional Clinical Cardiology Dispensary, Novosibirsk, Russian Federation
5Novosibirsk Military Regional Hospital No. 2, Novosibirsk, Russian Federation
Nowadays, the accumulated world experience of working in crisis situations shows that psychological assistance to patients experienced COVID-19 is provided mainly on a one-time basis — upon the fact of the incident, while the necessary subsequent psychological rehabilitation and preventive measures are not enough practiced. In most cases, the impact of a powerful stress factor is associated with an increase in the level of depression and anxiety, which can have a negative effect not only on the patient's life quality, but also on the prognosis, both short-term and long-term. The increased stress have an influence on the immunity decrease, which, in turn, reduces the threshold of resistance to infectious diseases, including COVID-19. In this regard, the WHO information note "Mental Health and Psychosocial Factors in the COVID-19 Outbreak", in addition to the appeal to the population during pandemic, contains recommendations for specialists providing various assistance types to preserve mental health and stabilize psychological state of the population. The presentation of current views on the problem of mental disorders during COVID-19 pandemic, both in patients and medical specialists, is the subject of this literature review.
Keywords: mental disorders, anxiety, depression, insomnia, pandemic, COVID-19, medical specialists.
For citation: Litvinenko P.I., Tsygankova O.V., Khidirova L.D., Starichkova A.A. Problems of mental disorder in the context of the COVID-19 pandemic. Russian Medical Inquiry. 2023;7(10):635–643 (in Russ.). DOI: 10.32364/2587-6821-2023-7-10-7.
About the authors:
Polina I. Litvinenko — clinical pharmacologist, Clinical Hospital "RZD-Medicine"; 2a, Vladimirovsky slope, Novosibirsk, 630003, Russian Federation; ORCID iD 0000-0002-5823-2555.
Oksana V. Tsygankova — Dr. Sc. (Med.), Professor of the Department of Emergency Therapy with Endocrinology and Occupational Pathology, Novosibirsk State Medical University; 52, Krasny Ave, Novosibirsk, 630091, Russian Federation; Senior Researcher of the Laboratory of Clinical Biochemical and Hormonal Studies of Therapeutic Diseases, Research Institute for Therapy and Preventive Medicine — Branch of the Federal Research Center Institute of Cytology and Genetics of the Siberian Branch of the RAS; 175/1 B, Bogatkova str., Novosibirsk, 630089, Russian Federation; ORCID iD 0000-0003-0207-7063.
Lyudmila Kh. Daudovna — Dr. Sc. (Med.), Professor of the Department of Pharmacology, Clinical Pharmacology and Evidence-based Medicine, Novosibirsk State Medical University; 52, Krasny avenue, Novosibirsk, 630091, Russian Federation; cardiologist, Novosibirsk Regional Clinical Cardiology Dispensary; 6, Zalessky str., Novosibirsk, 630047, Russian Federation; ORCID iD 0000-0002-1250-8798.
Anastasia A. Starichkova — Senior Laboratory Assistant of the Department of Emergency Therapy with Endocrinology and Occupational Pathology, Novosibirsk State Medical University; 52, Krasny Ave, Novosibirsk, 630091, Russian Federation; general practitioner, Novosibirsk Military Regional Hospital No. 2; 95a, Sem'i Shamshinykh str., Novosibirsk, 630005, Russian Federation; ORCID iD 0000-0002-8093-2371.
Contact information: Oksana V. Tsygankova, e-mail: oksana_c.nsk@mail.ru.
Financial Disclosure: the work was partly supported within the framework of the state financed topic Reg. No. 122031700094-5.
There is no conflict of interests.
Received 18.10.2022.
Revised 11.11.2022.
Accepted 06.12.2022.
2. Cénat J.M., Blais-Rochette C., Kokou-Kpolou C.K. et al. Prevalence of symptoms of depression, anxiety, insomnia, posttraumatic stress disorder, and psychological distress among populations affected by the COVID-19 pandemic: A systematic review and meta-analysis. Psychiatry Res. 2021;295:113599. DOI: 10.1016/j.psychres.2020.113599.
3. COVID-19 Mental Disorders Collaborators. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 2021;398(10312):1700–1712. DOI: 10.1016/S0140-6736(21)02143-7.
4. Bueno-Notivol J., Gracia-García P., Olaya B. et al. Prevalence of depression during the COVID-19 outbreak: A meta-analysis of community-based studies. Int J Clin Health Psychol. 2021;21(1):100196. DOI: 10.1016/j.ijchp.2020.07.007.
5. Hossain M.M., Tasnim S., Sultana A. et al. Epidemiology of mental health problems in COVID-19: a review. F1000Res. 2020;9:636. DOI: 10.12688/f1000research.24457.1.
6. Xiong J., Lipsitz O., Nasri F. et al. Impact of COVID-19 pandemic on mental health in the general population: A systematic review. J Affect Disord. 2020;277:55–64. DOI: 10.1016/j.jad.2020.08.001.
7. Solomou I., Constantinidou F. Prevalence and Predictors of Anxiety and Depression Symptoms during the COVID-19 Pandemic and Compliance with Precautionary Measures: Age and Sex Matter. Int J Environ Res Public Health. 2020;17(14):4924. DOI: 10.3390/ijerph17144924.
8. Ho C.S., Chee C.Y., Ho R.C. Mental Health Strategies to Combat the Psychological Impact of Coronavirus Disease 2019 (COVID-19) Beyond Paranoia and Panic. Ann Acad Med Singap. 2020;49(3):155–160. DOI: 10.47102/annals-acadmedsg.202043.
9. Мадонов П.Г., Хидирова Л.Д., Деришева Д.А. Нейропсихиатрические особенности текущей пандемии COVID‑19 (анализ зарубежных публикаций 2020 года). Медицинский алфавит. 2020;(33):58–61. DOI: 10.33667/2078-5631-2020-33-58-61. [Madonov P.G., Khidirova L.D., Derisheva D.A. Neuropsychiatric features of current COVID-19 pandemic (analysis of foreign publications in 2020). Medical alphabet. 2020;(33):58–61 (in Russ.)]. DOI: 10.33667/2078-5631-2020-33-58-61.
10. Patel S.Y., Mehrotra A., Huskamp H.A. et al. Variation In Telemedicine Use And Outpatient Care During The COVID-19 Pandemic In The United States. Health Aff (Millwood). 2021;40(2):349–358. DOI: 10.1377/hlthaff.2020.01786.
11. Hao Q., Wang D., Xie M. et al. Prevalence and Risk Factors of Mental Health Problems Among Healthcare Workers During the COVID-19 Pandemic: A Systematic Review and Meta-Analysis. Front Psychiatry. 2021;12:567381. DOI: 10.3389/fpsyt.2021.567381.
12. Al Maqbali M., Al Sinani M., Al-Lenjawi B. Prevalence of stress, depression, anxiety and sleep disturbance among nurses during the COVID-19 pandemic: A systematic review and meta-analysis. J Psychosom Res. 2021;141:110343. DOI: 10.1016/j.jpsychores.2020.110343.
13. Li Y., Scherer N., Felix L., Kuper H. Prevalence of depression, anxiety and post-traumatic stress disorder in health care workers during the COVID-19 pandemic: A systematic review and meta-analysis. PLoS One. 2021;16(3):e0246454. DOI: 10.1371/journal.pone.0246454.
14. Castelli L., Di Tella M., Benfante A. et al. The psychological impact of COVID-19 on general practitioners in Piedmont, Italy. J Affect Disord. 2021;281:244–246. DOI: 10.1016/j.jad.2020.12.008.
15. Hurst K.T., Ballard E.D., Anderson G.E. et al. The mental health impact of contact with COVID-19 patients on healthcare workers in the United States. Psychiatry Res. 2022;308:114359. DOI: 10.1016/j.psychres.2021.114359.
16. Sahebi A., Nejati-Zarnaqi B., Moayedi S. et al. The prevalence of anxiety and depression among healthcare workers during the COVID-19 pandemic: An umbrella review of meta-analyses. Prog Neuropsychopharmacol Biol Psychiatry. 2021;107:110247. DOI: 10.1016/j.pnpbp.2021.110247.
17. Chutiyami M., Cheong A.M.Y., Salihu D. et al. COVID-19 Pandemic and Overall Mental Health of Healthcare Professionals Globally: A Meta-Review of Systematic Reviews. Front Psychiatry. 2022;12:804525. DOI: 10.3389/fpsyt.2021.804525.
18. Spoorthy M.S., Pratapa S.K., Mahant S. Mental health problems faced by healthcare workers due to the COVID-19 pandemic-A review. Asian J Psychiatr. 2020;51:102119. DOI: 10.1016/j.ajp.2020.102119.
19. Chen Y., Zhou H., Zhou Y., Zhou F. Prevalence of self-reported depression and anxiety among pediatric medical staff members during the COVID-19 outbreak in Guiyang, China. Psychiatry Res. 2020;288:113005. DOI: 10.1016/j.psychres.2020.113005.
20. Kang L., Ma S., Chen M. et al. Impact on mental health and perceptions of psychological care among medical and nursing staff in Wuhan during the 2019 novel coronavirus disease outbreak: A cross-sectional study. Brain Behav Immun. 2020;87:11–17. DOI: 10.1016/j.bbi.2020.03.028.
21. Mokhtari R., Moayedi S., Golitaleb M. COVID-19 pandemic and health anxiety among nurses of intensive care units. Int J Ment Health Nurs. 2020;29(6):1275–1277. DOI: 10.1111/inm.12800.
22. Marvaldi M., Mallet J., Dubertret C. et al. Anxiety, depression, trauma-related, and sleep disorders among healthcare workers during the COVID-19 pandemic: A systematic review and meta-analysis. Neurosci Biobehav Rev. 2021;126:252–264. DOI: 10.1016/j.neubiorev.2021.03.024.
23. Lu W., Wang H., Lin Y., Li L. Psychological status of medical workforce during the COVID-19 pandemic: A cross-sectional study. Psychiatry Res. 2020;288:112936. DOI: 10.1016/j.psychres.2020.112936.
24. Wong T.W., Yau J.K., Chan C.L. et al. The psychological impact of severe acute respiratory syndrome outbreak on healthcare workers in emergency departments and how they cope. Eur J Emerg Med. 2005;12(1):13–18. DOI: 10.1097/00063110-200502000-00005.
25. Cai H., Tu B., Ma J. et al. Psychological Impact and Coping Strategies of Frontline Medical Staff in Hunan Between January and March 2020 During the Outbreak of Coronavirus Disease 2019 (COVID‑19) in Hubei, China. Med Sci Monit. 2020;26:e924171. DOI: 10.12659/MSM.924171.
26. Бачило Е.В., Новиков Д.Е., Ефремов А.А. Оценка психического здоровья медицинских работников в период пандемии COVID-19 в России (результаты интернет-опроса). Журнал неврологии и психиатрии им. С.С. Корсакова. 2021;121(3):104–109. DOI: 10.17116/jnevro2021121031104. [Bachilo E.V., Novikov D.E., Efremov A.A. Mental health assessment of medical workers during the COVID-19 pandemic in Russia: results of an online survey. Zhurnal Nevrologii I Psikhiatrii imeni S.S. Korsakova. 2021;121(3):104–109 (in Russ.)]. DOI: 10.17116/jnevro2021121031104.
27. Fond G., Nemani K., Etchecopar-Etchart D. et al. Association Between Mental Health Disorders and Mortality Among Patients With COVID-19 in 7 Countries: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2021;78(11):1208–1217. DOI: 10.1001/jamapsychiatry.2021.2274.
28. Ceban F., Nogo D., Carvalho I.P. et al. Association Between Mood Disorders and Risk of COVID-19 Infection, Hospitalization, and Death: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2021;78(10):1079–1091. DOI: 10.1001/jamapsychiatry.2021.1818.
29. Shah M.M., Abbas S., Khan J.Z. et al. Psychological and Clinical Predictors of COVID-19 Severity and Outcomes. Cureus. 2021;13(11):e19458. DOI: 10.7759/cureus.19458.
30. Vai B., Mazza M.G., Delli Colli C. et al. Mental disorders and risk of COVID-19-related mortality, hospitalisation, and intensive care unit admission: a systematic review and meta-analysis. Lancet Psychiatry. 2021;8(9):797–812. DOI: 10.1016/S2215-0366(21)00232-7.
31. Deng J., Zhou F., Hou W. et al. The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis. Ann N Y Acad Sci. 2021;1486(1):90–111. DOI: 10.1111/nyas.14506.
32. Zarghami A., Farjam M., Fakhraei B. et al. A Report of the Telepsychiatric Evaluation of SARS-CoV-2 Patients. Telemed J E Health. 2020;26(12):1461–1465. DOI: 10.1089/tmj.2020.0125.
33. Wu T., Jia X., Shi H. et al. Prevalence of mental health problems during the COVID-19 pandemic: A systematic review and meta-analysis. J Affect Disord. 2021;281:91–98. DOI: 10.1016/j.jad.2020.11.117.
34. Liu C., Pan W., Li L. et al. Prevalence of depression, anxiety, and insomnia symptoms among patients with COVID-19: A meta-analysis of quality effects model. J Psychosom Res. 2021;147:110516. DOI: 10.1016/j.jpsychores.2021.110516.
35. Kang E., Lee S.Y., Kim M.S. et al. The Psychological Burden of COVID-19 Stigma: Evaluation of the Mental Health of Isolated Mild Condition COVID-19 Patients. J Korean Med Sci. 2021;36(3):e33. DOI: 10.3346/jkms.2021.36.e33.
36. Kim J.W., Kang H.J., Jhon M. et al. Associations Between COVID-19 Symptoms and Psychological Distress. Front Psychiatry. 2021;12:721532. DOI: 10.3389/fpsyt.2021.721532.
37. Kong X., Kong F., Zheng K. et al. Effect of Psychological-Behavioral Intervention on the Depression and Anxiety of COVID-19 Patients. Front Psychiatry. 2020;11:586355. DOI: 10.3389/fpsyt.2020.586355.
38. Saidi I., Koumeka P.P., Ait Batahar S., Amro L. Factors associated with anxiety and depression among patients with Covid-19. Respir Med. 2021;186:106512. DOI: 10.1016/j.rmed.2021.106512.
39. Ma Y.F., Li W., Deng H.B. et al. Prevalence of depression and its association with quality of life in clinically stable patients with COVID-19. J Affect Disord. 2020;275:145–148. DOI: 10.1016/j.jad.2020.06.033.
40. Kosovali B.D., Mutlu N.M., Gonen C.C. et al. Does hospitalisation of a patient in the intensive care unit cause anxiety and does restriction of visiting cause depression for the relatives of these patients during COVID-19 pandemic? Int J Clin Pract. 2021;75(10):e14328. DOI: 10.1111/ijcp.14328.
41. Полуэктов М.Г., Бузунов Р.В., Авербух В.М. и др. Проект клинических рекомендаций по диагностике и лечению хронической инсомнии у взрослых. Consilium Medicum. Неврология и Ревматология (Прил.). 2016;2:41–51. [Poluektov M.G., Buzunov R.V., Averbukh V.M. et al. Project of clinical recommendations on diagnosis and treatment of chronic insomnia in adults. Consilium Medicum. Neurology and Rheumatology (Suppl.). 2016;2:41–51 (in Russ.)].
42. Riemann D., Baglioni C., Bassetti C. et al. European guideline for the diagnosis and treatment of insomnia. J Sleep Res. 2017;26(6):675–700. DOI: 10.1111/jsr.12594.
43. Sateia M.J., Buysse D.J., Krystal A.D. et al. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017;13(2):307–349. DOI: 10.5664/jcsm.6470.
44. Han Q., Zheng B., Daines L., Sheikh A. Long-Term Sequelae of COVID-19: A Systematic Review and Meta-Analysis of One-Year Follow-Up Studies on Post-COVID Symptoms. Pathogens. 2022;11(2):269. DOI: 10.3390/pathogens11020269.
45. Nasserie T., Hittle M., Goodman S.N. Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19: A Systematic Review. JAMA Netw Open. 2021;4(5):e2111417. DOI: 10.1001/jamanetworkopen.2021.11417.
46. Платонов Д.Ю., Костюк Т.А., Брандт А.И., Цыганкова О.В. Детерминанты профилактического поведения в отношении сердечно-сосудистых заболеваний и факторов риска их развития у пациентов с гипертонической болезнью и хронической ишемической болезнью сердца. Рациональная фармакотерапия в кардиологии. 2011;7(6):718–724. DOI: 10.20996/1819-6446-2011-7-6-718-724. [Platonov D.Y., Kostjuk T.A., Brandt A.I., Tsygankova O.V. Determinants of preventive behavior regarding cardiovascular diseases and risk factors in patients with essential hypertension and chronic ischemic heart disease. Rational Pharmacotherapy in Cardiology. 2011;7(6):718–724 (in Russ.)]. DOI: 10.20996/1819-6446-2011-7-6-718-724.
47. Платонов Д.Ю., Костюк Т.А., Брандт А.И., Цыганкова О.В. Комплексная оценка профилактического поведения в отношении сердечно-сосудистых заболеваний и факторов риска их развития у больных гипертонической болезнью и хронической ишемической болезнью сердца. Профилактическая медицина. 2012;15(1):26–31. [Platonov D.I., Kostiuk T.A., Brandt A.I., Tsygankova O.V. Comprehensive evaluation of preventive behavior related to cardiovascular diseases and their risk factors in patients with hypertensive disease and chronic coronary heart disease. Profilakticheskaya Meditsina. 2012;15(1):26–31 (in Russ.)].
48. Wei N., Huang B.C., Lu S.J. et al. Efficacy of internet-based integrated intervention on depression and anxiety symptoms in patients with COVID-19. J Zhejiang Univ Sci B. 2020;21(5):400–404. DOI: 10.1631/jzus.B2010013.
49. Liu K., Chen Y., Wu D. et al. Effects of progressive muscle relaxation on anxiety and sleep quality in patients with COVID-19. Complement Ther Clin Pract. 2020;39:101132. DOI: 10.1016/j.ctcp.2020.101132.
50. Jenefer Jerrin R., Theebika S., Panneerselvam P. et al. Yoga and Naturopathy intervention for reducing anxiety and depression of Covid-19 patients — A pilot study. Clin Epidemiol Glob Health. 2021;11:100800. DOI: 10.1016/j.cegh.2021.100800.
51. Al-Alawi M., McCall R.K., Sultan A. et al. Efficacy of a Six-Week-Long Therapist-Guided Online Therapy Versus Self-help Internet-Based Therapy for COVID-19-Induced Anxiety and Depression: Open-label, Pragmatic, Randomized Controlled Trial. JMIR Ment Health. 2021;8(2):e26683. DOI: 10.2196/26683.
52. D'Onofrio G., Ciccone F., Placentino G. et al. Internet-Based Psychological Interventions during SARS-CoV-2 Pandemic: An Experience in South of Italy. Int J Environ Res Public Health. 2022;19(9):5425. DOI: 10.3390/ijerph19095425.
53. Perlmutter A. Immunological Interfaces: The COVID-19 Pandemic and Depression. Front Neurol. 2021;12:657004. DOI: 10.3389/fneur.2021.657004.
54. Nakamura Z.M., Nash R.P., Laughon S.L., Rosenstein D.L. Neuropsychiatric Complications of COVID-19. Curr Psychiatry Rep. 2021;23(5):25. DOI: 10.1007/s11920-021-01237-9.
55. De Sousa Moreira J.L., Barbosa S.M.B., Vieira J.G. et al. The psychiatric and neuropsychiatric repercussions associated with severe infections of COVID-19 and other coronaviruses. Prog Neuropsychopharmacol Biol Psychiatry. 2021;106:110159. DOI: 10.1016/j.pnpbp.2020.110159.
56. Da Silva Lopes L., Silva R.O., de Sousa Lima G. et al. Is there a common pathophysiological mechanism between COVID-19 and depression? Acta Neurol Belg. 2021;121(5):1117–1122. DOI: 10.1007/s13760-021-01748-5.
57. Хидирова Л.Д., Федорук В.А., Васильев К.О. Роль новой коронавирусной инфекции, вызванной вирусом SARS-CoV-2, в манифестации мультисистемного воспалительного синдрома. Профилактическая медицина. 2021;24(6):110–115. DOI: 10.17116/profmed202124061110. [Khidirova L.D., Fedoruk V.A., Vasiliev K.O. Role of the new coronavirus infection caused by the SARS-COV-2 virus in the manifestation of multisystem inflammatory syndrome. Profilakticheskaya Meditsina. 2021;24(6):110‑115 (in Russ.)]. DOI: 10.17116/profmed202124061110.
58. Старичкова А.А., Цыганкова О.В., Хидирова Л.Д. и др. Кардиометаболические нарушения при SARS-CoV-2-инфекции и постковидном синдроме. Лечащий Врач. 2022;3(25):49–58. DOI: 10.51793/OS.2022.25.3.008. [Starichkova A.A., Tsygankova O.V., Khidirova L.D. et al. Cardiometabolic disorders in SARS-CoV-2 infection and post-covid syndrome. Lechaschi Vrach. 2022;(3):49–58 (in Russ.)]. DOI: 10.51793/OS.2022.25.3.008.
This work is licensed under a Creative Commons «Attribution» 4.0 License.
Распечатать